Trademark Search  /  CELLAÏON

CELLAÏON

● Live · Registered

U.S. federal trademark · Serial No. 79346877 · Reg. No. 7318105

Mark
CELLAÏON
Status
Registered
Serial Number
79346877
Registration No.
7318105
Filing Date
June 16, 2022
Registration Date
March 5, 2024
Class(es)
Class 005, Class 042

Owners

Cellaïon, société anonyme
99 · BE
Cellaïon, société anonyme
99 · BE
Cellaïon, société anonyme
99 · BE

Goods & Services

Cells originating from human tissue, for medical, clinical or veterinary use, namely, liver derived cells and stem cells or liver progenitor cells; pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of diseases that require cell therapy medicinal products, namely, liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence; surgical implants comprised of living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; transplants being living tissue in the form of liver derived cells and stem cells or liver progenitor cells; live organs and tissues for surgical purpose in the field of liver derived cells and stem cells or liver progenitor cells; surgical implants comprising living tissue grown from stem cells or progenitor cells in the field of liver derived cells and stem cells or liver progenitor cells; cell-based pharmaceutical preparations in the field of liver derived cells and stem cells or liver progenitor cells for the treatment of liver diseases, chronic biliary diseases, cholestatic diseases, age-related diseases, bone and cartilage disorders, pancreatic diseases, kidney diseases, pulmonary diseases, cardiovascular diseases, eye diseases, ocular diseases, organ injury, organ failure, blood coagulation disorders, Clarkson disease, diabetes, skin diseases, cancer, metabolic diseases, inflammatory diseases, inflammation, neurodegenerative diseases, fibrotic diseases, proliferative diseases, infectious diseases, autoimmune diseases, diseases with unwanted immune response, sepsis, sepsis induced diseases, cellular senescence

Biomedical research and development services in relation to the testing of biological samples to determine the presence and activity of stem cells, progenitor cells and liver cells, in particular, liver stem cells and liver progenitor cells

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CELLAÏON" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.